Protocol for the development of a paediatric core outcome set for arthrogryposis multiplex congenita: an international multi-interest-holder consensus study

STRENGTHS AND LIMITATIONS OF THIS STUDY

  • An international advisory panel, including clinicians and individuals with lived experience, is supporting the ongoing core outcome set (COS) development process to identify outcome measures relevant to arthrogryposis.

  • Representation from diverse healthcare and cultural contexts across Canada, the USA, Poland, Australia and India provides global perspectives on assessment priorities and the applicability of the COS across different settings.

  • Engagement of clinicians and individuals with lived experience throughout the COS development process supports the inclusion of outcomes that are meaningful to the broader arthrogryposis community.

  • Purposive and snowball sampling, as well as the availability of consensus-building materials only in French and English, may influence the diversity of perspectives captured.

  • Introduction

    Three hundred million people are affected by 1 of approximately 7000 rare diseases around the world.1 Despite this staggering statistic, the input of individuals…
    This post was originally published on https://bmjopen.bmj.com